Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 8.20M | $799.0M | 14.96% | +432.2K | 2026-06-30 |
| BlackRock, Inc. | 4.12M | $401.0M | 7.53% | +948.1K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 3.89M | $379.0M | 7.10% | +2.60M | 2026-06-30 |
| Wellington Management Group LLP | 3.23M | $314.0M | 5.89% | +634.1K | 2026-06-30 |
| Fairmount Funds Management LLC | 2.54M | $247.0M | 4.63% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 2.51M | $245.0M | 4.59% | +1.37M | 2026-06-30 |
| State Street Corp | 2.36M | $229.0M | 4.30% | +958.5K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.16M | $210.0M | 3.94% | +128.3K | 2026-06-30 |
| Avidity Partners Management LP | 2.10M | $205.0M | 3.84% | -- | 2026-06-30 |
| Octagon Capital Advisors LP | 1.84M | $179.0M | 3.36% | -105.0K | 2026-06-30 |
